Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Doxofylline and Glucose Injection

Approval Number

国药准字H20030696

Company扬州中宝药业股份有限公司

Registration Date

June 24, 2020

Drug Information

Generic Name

多索茶碱葡萄糖注射液

Trade Name

中宝索迪

Dosage Form

注射剂

Strength

100ml:多索茶碱0.3g与葡萄糖5g

Drug Type

化学药品

Registration Date

June 24, 2020

Company Information

Applicant Company

Company Name扬州中宝药业股份有限公司

Manufacturing Company

Company Name扬州中宝药业股份有限公司

Company Address

江苏省扬州市宝应县经济开发区新区宝应大道91号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy